ClinicalTrials.gg
RecruitingNCT07789288Updated Oct 1, 2026

Hard Cervical Collar Use Following Posterior Cervical Fusion

An interventional study of Hard Cervical Collar in Spinal Stenosis Cervical, Radiculopathy, Cervical Region and Posterior Cervical Fusion, sponsored by Georgetown University. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Georgetown University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 1, 2026Study contact changedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Postoperative immobilization with a hard cervical collar following posterior cervical fusion remains common practice despite limited evidence demonstrating improved clinical outcomes. This is a prospective, multi-site, randomized clinical trial evaluating postoperative hard cervical collar use following posterior cervical fusion for degenerative cervical spine disease. Eligible patients will be randomized to either wear an FDA-approved hard cervical collar (Aspen Cervical Collar, Aspen Vista Cervical Collar, or Miami J Cervical Collar) for 6 weeks after surgery or receive no cervical collar. Patient-reported outcomes will be collected before surgery and at 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months after surgery. The primary outcome is radiographic fusion success at 12 months. Secondary outcomes include neck disability, neck and arm pain, quality of life, patient satisfaction, wound infection, adverse events, and other postoperative complications. Radiographic fusion will be evaluated by blinded radiologists. The results of this study will help determine whether routine postoperative cervical collar use improves outcomes following posterior cervical fusion.

02

Conditions studied

  • Spinal Stenosis Cervical
  • Radiculopathy, Cervical Region
  • Posterior Cervical Fusion
  • Spondylosis, Cervical
03

In context

Radiculopathy

483 studies on the registry are indexed under Radiculopathy; 145 are open to participants now.

This study's planned enrollment of 150 is above the median of 60 across 373 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Georgetown University is the lead sponsor of 292 studies on the registry; 40 are open to participants now.

Of its 28 completed or terminated interventional studies of FDA-regulated products, 20 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older
  • Diagnosis of degenerative disk disease (DDD)
  • Ability to provide
  • Patients with cervical spondylotic myelopathy, cervical deformity, or pseudoarthrosis

Exclusion criteria

Exclusion Criteria:

- Patients with trauma, tumors, or infections

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Collar

    Hard Cervical Collar for 6 weeks

    Device: Hard Cervical Collar

  • No intervention
    No collar

Interventions

  • DeviceHard Cervical Collar

    Participants randomized to this arm will wear a hard cervical collar continuously for 6 weeks following posterior cervical fusion. The collar may be briefly removed for hygiene purposes. FDA-approved cervical collars (Aspen Cervical Collar, Aspen Vista Cervical Collar, or Miami J Cervical Collar) will be used according to institutional practice.

06

What researchers measure

Primary outcomes

  1. Radiographic fusion success

    Fusion success following posterior cervical fusion as determined by blinded radiographic evaluation

    Time frame: 3, 6, 12 months after surgery

Secondary outcomes

  1. Neck Disability Index

    Patient-reported neck disability measured using the Neck Disability Index (NDI). Scores range from 0 to 50, with higher scores indicating greater neck-related disability.

    Time frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months after surgery

  2. EQ-5D-3L Quality of Life

    Patient-reported health-related quality of life measured using the EQ-5D-3L descriptive system and EQ visual analogue scale (EQ VAS). The EQ-5D-3L assesses five dimensions of health, each with three levels of severity. The EQ VAS ranges from 0 to 100, with higher scores indicating better self-rated health.

    Time frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months

  3. Numeric Rating Scale for Neck Pain

    Patient-reported neck pain severity measured using the Numeric Rating Scale (NRS). Scores range from 0 to 10, with higher scores indicating greater pain severity.

    Time frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months

  4. Numeric Rating Scale for Arm Pain

    Patient-reported arm pain severity measured using the Numeric Rating Scale (NRS). Scores range from 0 to 10, with higher scores indicating greater pain severity.

    Time frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months

  5. North American Spine Society Patient Satisfaction Index

    Patient-reported satisfaction measured using the North American Spine Society (NASS) Patient Satisfaction Index. Scores range from 1 to 4, with lower scores indicating greater satisfaction with treatment.

    Time frame: 6 weeks, 12 weeks, 6 months, and 12 months

  6. Wound infection rate

    Time frame: up to 12 months after surgery

07

Study locations

2 of 2 sites recruiting
08

Updates

1 registry update since Sep 25, 2026
Secondary outcomes
5 edited
What changed in the outcomes
  • EditedNeck Disability Index (NDI)Time frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months after surgery
  • EditedEQ-5D-3L Quality of LifeTime frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
  • EditedNumeric Rating Scale (NRS) for Neck PainTime frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
  • EditedNumeric Rating Scale (NRS) for Arm PainTime frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
  • EditedNorth American Spine Society (NASS) Patient Satisfaction IndexTime frame: 6 weeks, 12 weeks, 6 months, and 12 months
Oct 1, 2026
Contact
Study contact changed: added m•••@georgetown.edu. See the current contact
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Secondary outcomes 5 edited
    What changed in the outcomes
    • EditedNeck Disability Index (NDI)Time frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months after surgery
    • EditedEQ-5D-3L Quality of LifeTime frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
    • EditedNumeric Rating Scale (NRS) for Neck PainTime frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
    • EditedNumeric Rating Scale (NRS) for Arm PainTime frame: Baseline, 2 weeks, 6 weeks, 12 weeks, 6 months, and 12 months
    • EditedNorth American Spine Society (NASS) Patient Satisfaction IndexTime frame: 6 weeks, 12 weeks, 6 months, and 12 months
    Contact Study contact changed: added m•••@georgetown.edu. See the current contact
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07789288
Responsible party
Amjad Anaizi (Associate Professor of Neurosurgery at MedStar Georgetown University Hospital, Georgetown University) — Principal investigator
First posted
Aug 27, 2026
Start date
Jun 3, 2026
Primary completion
May 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Oct 1, 2026

Study contacts

Amjad Anaizi, MD
Contact
Amjad.N.Anaizi@gunet.georgetown.edu
301-856-2323
Min Ji Koh
Contact
mk2421@georgetown.edu
Amjad Anaizi, MD
principal investigator · MedStar Georgetown University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion